Skip to content

Author

Pei-Lun Liao

We have 2 of 44 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Comparative outcomes of GLP-1 receptor agonist and SGLT2 inhibitor users after liver transplantation: An emulated target trial.

OBJECTIVE We emulated a target trial to compare glucagon-like peptide-1 receptor agonists (GLP-1 RAs) with sodium-glucose cotransporter-2 inhibitors (SGLT2is) regarding hepatic, cardiovascular, and mortality outcomes among liver transplant recipients with diabetes. METHODS Using the TriNetX US Collaborative Network,...

F. Yen, Pei-Lun Liao, Yao-Min Hung et al. · 0 citations
Open access Jul 2026

Impact of dual antiplatelet therapy duration after percutaneous coronary intervention on outcomes in acute coronary syndrome patients with and without chronic kidney disease: a nationwide cohort study

In prespecified subgroup analyses, prolonged DAPT was associated with a higher incidence of bleeding events among patients with claims-defined CKD; however, this finding should be interpreted as exploratory given the observational design and low event rates.

Kai-Wei Chang, Pei-Lun Liao, Jing-Yang Huang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.